PRDX1 promotes clear cell renal cell carcinoma progression by modulating EGFR-dependent AKT pathway activation

BackgroundRenal cell carcinoma (RCC) is a highly heterogeneous malignant tumor, characterized by a globally increasing incidence and mortality rate. Although surgical resection serves as the standard treatment for localized RCC, recurrence and metastasis remain major clinical challenges. Based on pa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zhi Liang, Xiaochun Lin, Shen Zeng, Lili Wu, Yujun Dong, Chen Zhang, Mei Li, Fudi Zhu, Lu Chen, Suiqin Ni
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-04-01
Serie:	Frontiers in Pharmacology
Soggetti:	clear cell renal cell carcinoma clinical prognosis EGFR signaling pathway peroxiredoxin 1 survival rate
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1741879/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!